Literature DB >> 6610418

Tumoricidal activation of murine alveolar macrophages by muramyldipeptide substituted mannosylated serum albumin.

M Monsigny, A C Roche, P Bailly.   

Abstract

Rat and mouse alveolar macrophages have almost no spontaneous tumoricidal activity and are only slightly activated by muramyldipeptide (MDP). When MDP was carried by serum albumin, the activation was higher than with free MDP but only at high concentration. When MDP was bound to a neoglycoprotein (mannosylated serum albumin) - which binds to the sugar binding receptor at the macrophage cell surface and is actively endocytosed - the activation of rat or mouse alveolar macrophages is dramatically enhanced even at very low concentration of neoglycoprotein -bound MDP. Furthermore, neoglycoprotein -bound MDP injected i.v. or i.p. was found to be able to activate alveolar macrophages, the activity of which was maximal after 48 hours in mice and 72 hours in rats. Such conjugates have so potential values as new immunostimulant agents in cancer and parasite therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6610418     DOI: 10.1016/0006-291x(84)90221-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Antileishmanial drug targeting through glycosylated polymers specifically internalized by macrophage membrane lectins.

Authors:  E Nègre; M L Chance; S Y Hanboula; M Monsigny; A C Roche; R M Mayer; M Hommel
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

2.  Lactotransferrin receptor of mouse small-intestinal brush border. Binding characteristics of membrane-bound and triton X-100-solubilized forms.

Authors:  W L Hu; J Mazurier; G Sawatzki; J Montreuil; G Spik
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

3.  Immunoassay for native enzyme quantification in biological samples.

Authors:  C de Bellefontaine; F Josse; M Domurado; D Domurado
Journal:  Appl Biochem Biotechnol       Date:  1994-08       Impact factor: 2.926

Review 4.  Gene therapy of cystic fibrosis: the glycofection approach.

Authors:  I Fajac; P Briand; M Monsigny
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

5.  Muramyl dipeptide bound to poly-L-lysine substituted with mannose and gluconoyl residues as macrophage activators.

Authors:  D Derrien; P Midoux; C Petit; E Nègre; R Mayer; M Monsigny; A C Roche
Journal:  Glycoconj J       Date:  1989       Impact factor: 2.916

6.  Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates.

Authors:  E Bonfils; C Depierreux; P Midoux; N T Thuong; M Monsigny; A C Roche
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

7.  Selective macrophage activation by muramyldipeptide bound to monoclonal antibodies specific for mouse tumor cells.

Authors:  A C Roche; P Bailly; P Midoux; M Monsigny
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.